65 results about "Ventricular volume" patented technology

The symptoms of congenital heart failure are addressed in this surgical procedure for mounting a patch in the ventricle of the heart to reduce ventricular volume. Placement of the patch is facilitated by palpating a beating heart to identify akinetic, although normal appearing, tissue. The patch has an oval configuration facilitating return of the heart to a normal apical shape which enhances muscle fiber efficiency and a normal writhing pumping action. The patch includes a semi-rigid ring, and a circumferential rim to address bleeding. Patch placement is further enhanced by creating a Fontan neck and use of pledged sutures. Intraoperative vascularization and valve replacement is easily accommodated. Increased injection fraction, reduced muscle stress, improved myocardial protection, and ease of accurate patch placement are all achieved with this procedure.

Devices and systems including implants (which may be removable) and methods of using them for reducing ventricular volume. The implants described herein are cardiac implants that may be inserted into a patient's heart, particularly the left ventricle. The implant may support the heart wall, or may be secured to the heart wall. The implants are typically ventricular partitioning device for partitioning the ventricle into productive and non-productive regions in order to reduce the ventricular volume.

Apparatus and methods to reduce ventricular volume are disclosed. The device takes the form of a transventricular anchor, which presses a portion of the ventricular wall inward, thereby reducing the available volume of the ventricle. The anchor is deployed using a curved introducer that may be inserted into one ventricle, through the septum and into the opposite ventricle. Barbs or protrusions along the anchor body combined with a mechanical stop and a sealing member hold the device in place once deployed.

This document discusses, among other things, systems, devices, and methods measure an impedance and, in response, adjust an atrioventricular (AV) delay or other cardiac resynchronization therapy (CRT) parameter that synchronizes left and right ventricular contractions. A first example uses parameterizes a first ventricular volume against a second ventricular volume during a cardiac cycle, using a loop area to create a synchronization fraction (SF). The CRT parameter is adjusted in closed-loop fashion to increase the SF. A second example measures a septal-freewall phase difference (PD), and adjusts a CRT parameter to decrease the PD. A third example measures a peak-to-peak volume or maximum rate of change in ventricular volume, and adjusts a CRT parameter to increase the peak-to-peak volume or maximum rate of change in the ventricular volume.

This document discusses, among other things, systems, devices, and methods measure an impedance and, in response, adjust an atrioventricular (AV) delay or other cardiac resynchronization therapy (CRT) parameter that synchronizes left and right ventricular contractions. A first example uses parameterizes a first ventricular volume against a second ventricular volume during a cardiac cycle, using a loop area to create a synchronization fraction (SF). The CRT parameter is adjusted in closed-loop fashion to increase the SF. A second example measures a septal-freewall phase difference (PD), and adjusts a CRT parameter to decrease the PD. A third example measures a peak-to-peak volume or maximum rate of change in ventricular volume, and adjusts a CRT parameter to increase the peak-to-peak volume or maximum rate of change in the ventricular volume.

A cardiac insert or implant is deployed in a patient's heart so as to reduce ventricular volume, thereby improving cardiac function. The insert or implant may be a compressive device such as a tensile member inserted into the patient's heart, and thereafter operated or deployed to bring opposite walls of a ventricle of the patient's heart into at least approximate contact with one another to thereby constrict and close off a lower portion of that ventricle. The compressive device or tensile member is insertable into the patient heart via a catheter threaded through the patient's vascular system and into the patient's heart.

An adjustable drainage system for regulating cerebrospinal fluid flow in a hydrocephalus patient where the drainage rate is adjusted in response to ventricular volume variations in the patient. The system includes an adjustable valve and a volume sensor that can be periodically energized with an external system controller device by the patient or attending physician to determine when, or if, a change in the ventricular volume has occurred. The system enables the user to adjust the valve's resistance in response to changes in the ventricular volume using the controller device so that a target ventricular volume can be achieved. Also provided is a method of continuously draining cerebrospinal fluid from the cranial cavity of the patient using the system of the present invention.

In a method and implantable medical device for ventricular tachyarrhythmia detection and classification, upon detection of a ventricular tachyarrhythmia based on an electrocardiogram signal, cardiogenic impedance data representative of ventricular volume dynamics are collected and used for classifying the detected tachyarrhythmia as stable or unstable. In the latter case but typically not in the former case, defibrillation shocks or other forms of therapy are applied to combat the unstable ventricular tachyarrhythmia.

A method and apparatus are presented for acquiring MR cardiac images in a time equivalent to a single breath-hold. MR data acquisition is segmented across multiple cardiac cycles. MR data acquisition is interleaved from each phase of a first cardiac cycle with MR data from each phase of a subsequent cardiac cycle. Preferably, low spatial frequency data are interleaved between multiple cardiac cycles, and the subsequent cardiac cycle acquisition includes sequential acquisition of high spatial frequency data towards the end of the acquisition window. An MR image can then be reconstructed with data acquired from each of the acquisitions that reduce ghosting and artifacts. Volume images of the heart can be produced within a single breath-hold. Images can be acquired throughout the cardiac cycle to measure ventricular volumes and ejection fractions. Single phase volume acquisitions can also be performed to assess myocardial infarction.

The invention discloses a medical cardiac tamponade object and relates to the field of medical instruments. The medical cardiac tamponade object comprises a supporting frame and a base. The supporting frame is composed of a plurality of developing units, a plurality of fixing tips, a plurality of umbrella-rib-shaped sectional rods and a plurality of cambered surfaces. Every two adjacent umbrella-rib-shaped sectional rods are connected through one cambered surface to form the inverted-umbrella-shaped supporting frame, wherein the umbrella periphery of the supporting frame is turned outwards with the outward-turning angle ranging from 0 degree to 90 degrees. One end of each umbrella-rib-shaped sectional rod is connected with one corresponding fixing tip erected on the umbrella periphery of the supporting frame. Each fixing tip is provided with one developing unit. All the umbrella-rib-shaped sectional rods and all the fixing tips are coated with polymer separation films respectively. The bottom of the supporting frame is connected with the base. The bottom of the base is a plane. Being in the inverted umbrella shape, the medical cardiac tamponade object can effectively reduce the ventricular volume and reduce ventricular tension, thereby improving ventricular remodeling and cardiac functions of a patient.

A diagnostic imaging apparatus includes a ventricular volume-variation measuring unit that measures sequential variations in a size of a ventricle within at least one heart beat, from images of a heart scanned in each of a plurality of time phases; a scanning-condition setting unit that specifies a time phase of little cardiac motion based on variations in the size of the ventricle measured by the ventricular volume-variation measuring unit, and sets scanning conditions so as to collect data in the specified time phase; and an imaging unit that collects data based on the scanning conditions set by the scanning-condition setting unit, and reconstructs an image from the collected data.

A cardiac stimulator having at least one stimulation unit which is connected or connectable to one or more stimulation electrodes, and is configured to deliver at least sub-threshold stimulation pulses for cardiac contraction modulation therapy, an impedance detection unit which is connectable to one or more electrodes, and is configured to detect a voltage or current intensity that occurs as the result of a particular sub-threshold stimulation pulse, and to determine a particular impedance value, an impedance evaluation unit, configured to determine at least one value based on ventricular volume, and/or a value based on minute ventilation, and a control unit connected to the stimulation unit and the cardiac rhythm detection unit, and is configured to control a delivery of a stimulation pulse via the stimulation unit such that the cardiac stimulator can deliver sub-threshold stimulation pulses for cardiac contraction modulation therapy.

The invention discloses a cardiac impulse assist system, which comprises a ventricular volume regulating device, a synchronizer and a control device, wherein the ventricular volume regulating device is used for regulating ventricular volumes; a sensor of the synchronizer is connected to the heart; the synchronizer is used for collecting ventricular systole signals; and the control device is used for receiving the ventricular systole signals collected by the synchronizer, and is used for controlling the ventricular volume regulating device to synchronously reduce the ventricular volumes when ventricular systole is performed. An automatic defibrillating device and a synchronous treatment device are arranged in the synchronizer; a defibrillating electrode of the automatic defibrillating device is connected to the heart; a pacing electrode of the synchronous treatment device is implanted into a chamber of the heart. As the ventricular volume regulating device is small in size, the cardiac impulse assist system disclosed by the invention can be implanted into the chamber of the heart. The cardiac impulse assist system disclosed by the invention can be used for completely imitating a ventricular pressure-volume change rule, can work synchronously with cardiac impulse, and can be used for assist the heart to pulsate and do work so as to treat cardiac failure, promote ventricular restoration and repair the perforation of ventricular septum.

The application discloses a ventricular volume reduction device that can be expanded or stretched into a strip shape. The ventricular volume reduction device includes a first bracket and a second bracket with the axes coinciding with each other. The first bracket includes a closed first connecting end and an expanded first edge. The first bracket is gradually expanded along a direction from the first connecting end to the first edge. The second bracket includes a closed second connecting end and an expanded second edge. The second bracket is gradually expanded along a direction from the secondconnecting end to the second edge. The first edge is connected with the second edge, and the first bracket is rotatable around the connecting part of the first edge and the second edge. The first connecting end is provided with a first connecting member, and the second connecting end is provided with a second connecting member. The first connecting member and the second connecting member are respectively used for connecting a delivery system. At least one surface of the first bracket and the second bracket is covered with a flow blocking membrane. The application further provides a delivery system that achieves accurate operation and recycling.